Acne and rosacea, two of the most common skin diseases, were on the mind during the American Academy of Dermatology’s (AAD) 2017 Summer Meeting. Industry experts joined to discuss what is new on the two conditions, including recent research and treatments.
Read on for a sample of the topics discussed in the session, directed by Hilary Baldwin, M.D.
In her presentation on the topic, Hormonal Therapy for Acne: Pros and Controversies, Bethanee Schlosser, M.D., weighed various options for hormonal treatment, such as combined oral contraceptives and off-label use of the diuretic spironolactone. Patients and clients should be screened for hormonal therapy by taking a thorough history to ensure that no contraindications exist.